VIR
Vir Biotechnology, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Vir Biotechnology, Inc.
11.46
No thesis.
−3.79%
vs ±11.6% implied · ×0.33
shaded = implied · ▲▼ = realized
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $210.7M | 14.05% | +14.89% | |
| 2 | Arch VentureArch Venture | $129.4M | 8.63% | −1.72% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $117.1M | 7.81% | +24.74% | |
| 4 | SB Investment Advisers (uk)SB Investment Advisers (uk) | $111.6M | 7.44% | 0.00% | |
| 5 | State StreetState Streetindex-like | $101.5M | 6.77% | +39.53% | |
| 6 | GlaxosmithklineGlaxosmithkline | $87.1M | 5.81% | 0.00% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $65.1M | 4.34% | +18.70% | |
| 8 | Point72 Asset ManagementPoint72 | $57.7M | 3.85% | +190.27% | |
| 9 | Geode Capital ManagementGeodeindex-like | $34.1M | 2.28% | +25.98% | |
| 10 | Dimensional Fund AdvisorsDimensional | $31.8M | 2.12% | +20.92% | |
| 11 | ADAR1 Capital ManagementADAR1 | $25.0M | 1.67% | −10.49% | |
| 12 | Goldman Sachs GroupGoldman Sachs | $24.1M | 1.61% | −27.23% | |
| 13 | FMRFMR | $23.6M | 1.58% | +11.89% | |
| 14 | Morgan StanleyMorgan Stanley | $22.5M | 1.50% | −22.53% | |
| 15 | NuveenNuveenindex-like | $20.2M | 1.35% | +94.60% | |
| 16 | Pictet Asset Management HoldingPictet | $19.9M | 1.33% | +31.91% | |
| 17 | Boxer Capital ManagementBoxer | $19.0M | 1.27% | 0.00% | |
| 18 | Northern TrustNorthern Trustindex-like | $14.6M | 0.97% | +45.33% | |
| 19 | Hudson Bay Capital ManagementHudson Bay | $13.9M | 0.93% | −7.18% | |
| 20 | GordonMD Global InvestmentsGordonMD Global | $13.8M | 0.92% | −10.87% | |
| 21 | Charles Schwab Investment ManagementCharles Schwabindex-like | $13.5M | 0.90% | +12.93% | |
| 22 | Bank of AmericaBank of America | $11.6M | 0.78% | +18.30% | |
| 23 | Two Sigma InvestmentsTwo Sigma | $11.3M | 0.75% | −22.87% | |
| 24 | Sio Capital ManagementSio | $11.0M | 0.73% | −28.25% | |
| 25 | Citadel AdvisorsCitadel | $10.6M | 0.71% | −52.60% |
237 managers report $1.5B of Vir Biotechnology on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; BlackRock is largest at 14.05%.
Linked news
Expected move
Inputsspot 11.30exp Nov 20ATM strike 11ATM straddle 1.52IV 71%